株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

動物用ワクチンの世界市場:分析と予測

Global Veterinary Animal Vaccines Market Research Report Forecast to 2025

発行 Market Research Future 商品コード 872601
出版日 ページ情報 英文 133 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。
Back to Top
動物用ワクチンの世界市場:分析と予測 Global Veterinary Animal Vaccines Market Research Report Forecast to 2025
出版日: 2019年05月31日 ページ情報: 英文 133 Pages
概要

当レポートでは、世界の動物用ワクチン市場について調査分析し、市場力学、市場動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 序文

第2章 エグゼクティブサマリー

第3章 市場イントロダクション

第4章 調査手法

第5章 市場力学

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会

第6章 市場要因分析

  • ファイブフォース分析
  • サプライチェーン分析

第7章 世界の動物用ワクチン市場:種類別

  • イントロダクション
    • 家畜用
    • 豚用
    • ペット用
    • 家禽用
    • 水産養殖用

第8章 世界の動物用ワクチン市場:技術別

  • イントロダクション
    • 弱毒化生ワクチン (LAV)
    • 不活化ワクチン
    • 組み換えワクチン
    • トキソイドワクチン

第9章 世界の動物用ワクチン市場:地域別

  • イントロダクション
  • 南北アメリカ
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢

  • イントロダクション

第11章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • Zoetis
  • Ceva
  • MSD & Co. Inc.
  • Elanco
  • Virbac
  • Phibro Animal Health Corporation
  • Hipra
  • IDT Biologika GmbH
  • Biogenesis Bago SA

第12章 付録

図表

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 4 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 5 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 6 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 7 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR PORCINE VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 8 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 9 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR POULTRY VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 10 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR AQUACULTURE VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 11 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 12 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVE ATTENUATED VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 13 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR INACTIVATED VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 14 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR RECOMBINANT VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 15 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR TOXOID VACCINES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 16 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 17 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 18 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 19 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 20 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 21 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 22 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2025 (USD MILLION)
  • TABLE 23 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 24 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 25 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 26 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 27 US: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 28 US: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 29 US: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 30 US: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 31 CANADA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 32 CANADA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 33 CANADA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 34 CANADA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 35 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 36 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 37 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 38 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 39 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 40 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 41 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 42 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 43 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 44 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2025 (USD MILLION)
  • TABLE 45 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 46 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 48 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 49 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 50 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 51 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 52 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 53 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 54 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 55 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 56 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 57 UK: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 58 UK: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 59 UK: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 60 UK: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 61 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 62 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 63 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 64 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 65 ITALY: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 66 ITALY: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 67 ITALY: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 68 ITALY: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 69 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 70 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 71 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 72 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 73 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 74 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 75 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 76 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 77 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2025 (USD MILLION)
  • TABLE 78 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 79 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 82 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 83 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 84 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 85 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 86 CHINA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 87 CHINA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 88 CHINA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 89 CHINA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 90 INDIA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 91 INDIA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 92 INDIA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 93 INDIA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 94 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 95 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 96 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 97 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 98 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 99 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 100 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 101 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 102 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 103 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 104 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 105 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 106 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 107 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 108 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 109 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 110 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 111 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 112 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 113 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 114 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)
  • TABLE 115 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 116 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 117 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 118 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2015-2025 (USD MILLION)

List of Figures

  • FIGURE 1 RESEARCH PROCESS
  • FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL VETERINARY/ANIMAL VACCINES MARKET
  • FIGURE 4 PORTER'S FIVE FORCES ANALYSIS: GLOBAL VETERINARY/ANIMAL VACCINES MARKET
  • FIGURE 5 SUPPLY CHAIN: GLOBAL VETERINARY/ANIMAL VACCINES MARKET
  • FIGURE 6 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2017 (% SHARE)
  • FIGURE 7 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2017 & 2025
  • FIGURE 8 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY,2017 (% SHARE)
  • FIGURE 9 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2017 & 2025
  • FIGURE 10 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2017 (% SHARE)
  • FIGURE 11 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2017 & 2025 (USD MILLION)
  • FIGURE 12 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2017 (% SHARE)
  • FIGURE 13 EUROPE: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2017 (% SHARE)
  • FIGURE 14 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY COUNTRY, 2017 (% SHARE)
  • FIGURE 15 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2017 (% SHARE)
  • FIGURE 16 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, MARKET SHARE ANALYSIS 2017 (%)
目次

Introduction

Veterinary vaccines are used to prevent infectious diseases caused by various agents and to provide protection to animals from various life-threatening disorders and diseases. Majority of the products are used for immunization of companion animals, ruminants, swine, poultry, and aqua animals and organisms. Veterinary vaccination has been proved helpful in the prevention of the outbreak of livestock diseases.

Factors influencing the market growth are the rising adoption rates of companion animals; increasing livestock population; frequent outbreaks of livestock diseases coupled with several advances in the technology of veterinary vaccines; and various initiatives taken by government agencies, animal associations, and prominent market players to increase awareness about the importance of animal/veterinary vaccines. On the other hand, high costs incurred for storing these vaccines to ensure potency can limit the growth of this market during the forecast period.

The global veterinary/animal vaccines market has been segmented on the basis of type, technology, and region. Based on type, the market has been divided into livestock vaccines, porcine vaccines, companion animal vaccines, poultry vaccines, and aquaculture vaccines. The livestock vaccines segment is further classified as bovine vaccines and small ruminant vaccines. The companion animal vaccines segment is further classified as canine vaccines, feline vaccines, and others. Based on technology, the global veterinary/animal vaccines market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others.

The global veterinary/animal vaccines market accounted for USD 6,074.05 million in 2017 and is expected to register a CAGR of 6.38 % during the forecast period.

Key Players

Some of the key players in the global veterinary/animal vaccines market are Boehringer Ingelheim International GmbH, Zoetis, Ceva, MSD & Co. Inc, Elanco, Virbac, Phibro Animal Health Corporation, Hipra., IDT Biologika GmbH, Biogenesis Bago SA, and others.

Study Objectives

  • To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global veterinary/animal vaccines market
  • To provide insights into factors influencing and affecting market growth
  • To provide historical, current, and forecast revenue of market segments based on type and technology
  • To provide historical, current, and forecast revenue of market segments and sub-segments concerning regional markets and key countries
  • To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
  • To provide economic factors, technology trends, and market trends that influence the global veterinary/animal vaccines market

Target Audience

  • Animal vaccine manufacturers
  • Animal healthcare product manufacturers
  • Animal vaccine distributors and wholesalers
  • Animal welfare associations
  • Veterinary clinics and care centers
  • Academic institutes and universities

Key Findings

  • The global veterinary/animal vaccines market is expected to reach a value of USD 9,910.59 million by 2025 at a CAGR of 6.38%.
  • On the basis of type, the livestock vaccines segment is projected to be larger, registering a CAGR of 4.87% during the forecast period.
  • By technology, the live attenuated vaccines segment is expected to be larger to be valued at USD 3,637.29 million by 2025.
  • On the basis of region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas accounted for the largest market share of 42.03% in 2017.
  • Asia-Pacific is projected to be the fastest-growing market at a CAGR of 7.29% from 2018 to2025.

The report also offers a regional analysis,

  • Americas
    • North America
  • US
  • Canada
    • Latin America
  • Europe
    • Western Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
    • Eastern Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa

Table of Contents

1 Report Prologue

2 Executive Summary

3 Market Introduction

  • 3.1 Definition
  • 3.2 Scope of the Study
  • 3.3 Research Objective
  • 3.4 Assumptions & Limitations
    • 3.4.1 Assumptions
    • 3.4.2 Limitations
  • 3.5 Market Structure

4 Research Methodology

  • 4.1 Research Process
  • 4.2 Primary Research
  • 4.3 Secondary Research
  • 4.4 Market Size Estimation
  • 4.5 Forecast Model

5 Market Dynamics

  • 5.1 Introduction
  • 5.2 Drivers
    • 5.2.1 Increasing Number of Pet Owners
    • 5.2.2 Growing Livestock Population and Disease Outbreaks
    • 5.2.3 Advances in Technology underlying Veterinary Vaccines
    • 5.2.4 Various Initiatives by Several Government Agencies, Animal Associations, and Prominent Market Players
  • 5.3 Restraint
    • 5.3.1 High Storage Cost associated with Veterinary Vaccines
  • 5.4 Opportunity
    • 5.4.1 Rising Investments to Improve Animal Health

6 Market Factor Analysis

  • 6.1 Porter's Five Forces Model
    • 6.1.1 Bargaining Power of Suppliers
    • 6.1.2 Bargaining Power of Buyers
    • 6.1.3 Threat of New Entrants
    • 6.1.4 Threat of Substitutes
    • 6.1.5 Rivalry
  • 6.2 Supply Chain Analysis
    • 6.2.1 R&D and Development
    • 6.2.2 Manufacturing
    • 6.2.3 Distribution & Sales
    • 6.2.4 Post-Sales Monitoring

7 Global Veterinary/Animal Vaccines Market, by Type

  • 7.1 Introduction
    • 7.1.1 Livestock Vaccines
    • 7.1.2 Porcine Vaccines
    • 7.1.3 Companion Animal Vaccines
    • 7.1.4 Poultry Vaccines
    • 7.1.5 Aquaculture Vaccines

8 Global Veterinary/Animal Vaccines Market, by Technology

  • 8.1 Introduction
    • 8.1.1 Live Attenuated Vaccines
    • 8.1.2 Inactivated Vaccines
    • 8.1.3 Recombinant Vaccines
    • 8.1.4 Toxoid Vaccines

9 Global Veterinary/Animal Vaccines Market, by Region

  • 9.1 Introduction
  • 9.2 Americas
    • 9.2.1 North America
      • 9.2.1.1 US
      • 9.2.1.2 Canada
    • 9.2.2 South America
  • 9.3 Europe
    • 9.3.1 Western Europe
      • 9.3.1.1 France
      • 9.3.1.2 Germany
      • 9.3.1.3 UK
      • 9.3.1.4 Spain
      • 9.3.1.5 Italy
      • 9.3.1.6 Rest of Western Europe
    • 9.3.2 Eastern Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Republic of Korea
    • 9.4.6 Rest of Asia-Pacific
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East
    • 9.5.2 Africa

10 Competitive Landscape

  • 10.1 Introduction

11 Company Profiles

  • 11.1 Boehringer Ingelheim International GmbH
    • 11.1.1 Company Overview
    • 11.1.2 Financial Overview
    • 11.1.3 Products/Services Offered
    • 11.1.4 Key Developments
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Strategies
  • 11.2 Zoetis
    • 11.2.1 Company Overview
    • 11.2.2 Financial Overview
    • 11.2.3 Products/Services Offered
    • 11.2.4 Key Developments
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Strategies
  • 11.3 Ceva
    • 11.3.1 Company Overview
    • 11.3.2 Financial Overview
    • 11.3.3 Products/Services Offered
    • 11.3.4 Key Developments
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Strategies
  • 11.4 MSD & Co. Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Financial Overview
    • 11.4.3 Products/Services Offered
    • 11.4.4 Key Developments
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Strategies
  • 11.5 Elanco
    • 11.5.1 Company Overview
    • 11.5.2 Financial Overview
    • 11.5.3 Products/Services Offered
    • 11.5.4 Key Developments
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Strategies
  • 11.6 Virbac
    • 11.6.1 Company Overview
    • 11.6.2 Financial Overview
    • 11.6.3 Products/Services Offered
    • 11.6.4 Key Developments
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Strategies
  • 11.7 Phibro Animal Health Corporation.
    • 11.7.1 Company Overview
    • 11.7.2 Financial Overview
    • 11.7.3 Products/Services Offered
    • 11.7.4 Key Developments
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Strategies
  • 11.8 Hipra
    • 11.8.1 Company Overview
    • 11.8.2 Financial Overview
    • 11.8.3 Products/Services Offered
    • 11.8.4 Key Developments
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Strategies
  • 11.9 IDT Biologika GmbH
    • 11.9.1 Company Overview
    • 11.9.2 Financial Overview
    • 11.9.3 Products/Services Offered
    • 11.9.4 Key Developments
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Strategies
  • 11.1 Biogenesis Bago SA
    • 11.10.1 Company Overview
    • 11.10.2 Financial Overview
    • 11.10.3 Products/Services Offered
    • 11.10.4 Key Developments
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Strategies

12 Appendix

  • 12.1 Discussion Blue Print
Back to Top